Benign whole body tumor volume is a risk factor for malignant peripheral nerve sheath tumors in neurofibromatosis type 1

Journal of Neuro-Oncology

Volumn 116, Issue 2, 2014, Pages 307-313

  Nguyen, Rosa ^a   Jett, Kimberly ^b   Harris, Gordon J ^c   Cai, Wenli ^c   Friedman, Jan M ^b   Mautner, Victor Felix ^d  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Malignant peripheral nerve sheath tumor; MRI scan; Neurofibromatosis 1; Plexiform neurofibroma; Whole body MRI

Indexed keywords

ADULT; AGE; ARTICLE; CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MALIGNANT PERIPHERAL NERVE SHEATH TUMOR; NEUROFIBROMATOSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; RISK ASSESSMENT; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CHILD; FEMALE; HUMANS; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROFIBROMATOSIS 1; PERIPHERAL NERVOUS SYSTEM NEOPLASMS; RISK FACTORS; STATISTICS, NONPARAMETRIC; TUMOR BURDEN; YOUNG ADULT;

EID: 84893647564     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-013-1293-1     Document Type: Article

References (13)

1. Evans DGR, O'Hara C, Wilding A et al (2011) Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989. Eur J Hum Genet 19:1187-1191
2. Rasmussen S, Yang Q, Friedman J (2001) Mortality in neurofibromatosis 1: an analysis using US death certificates. Am J Hum Genet 68:1110-1118
3. Evans DGR, Baser ME, McGaughran J et al (2002) Malignant peripheral nerve sheath tumors in neurofibromatosis 1. J Med Genet 39:311-314
4. Tucker T, Wolkenstein P, Revuz J et al (2005) Association between benign and malignant peripheral nerve sheath tumors in NF1. Neurology 65:205-211
5. Mautner VF, Asuagbor FA, Dombi E et al (2008) Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1. Neuro-oncology 10:593-598
6. Mautner VF, Hartmann M, Kluwe L et al (2006) MRI growth patterns of plexiform neurofibromas in patients with neurofibromatosis type 1. Neuroradiology 48:160-165
7. Cai W, Kassarjian A, Bredella MA et al (2009) Tumor burden in patients with neurofibromatosis types 1 and 2 and schwannomatosis: determination on whole-body MR images. Radiology 250:665-673
8. Friedrich RE, Korf B, Fünsterer C, Mautner VF (2003) Growth type of plexiform neurofibromas in NF1 determined on magnetic resonance images. Anticancer Res 23:949-952
9. Evans DG, Huson SM, Birch JM (2012) Malignant peripheral nerve sheath tumours in inherited disease. Clin Sarcoma Res 2:17
10. Cashen DV, Parisien RC, Raskin K et al (2004) Survival data for patients with malignant schwannoma. Clin Orthop Relat Res 426:69-73
11. Nguyen R, Dombi E, Widemann BC et al (2012) Growth dynamics of plexiform neurofibromas: a retrospective cohort study of 201 patients with neurofibromatosis 1. Orphanet J Rare Dis 7:75
12. Solomon J, Warren K, Dombi E et al (2004) Automated detection and volume measurement of plexiform neurofibromas in neurofibromatosis 1 using magnetic resonance imaging. Comput Med Imaging Graph 28:257-265
13. Mautner VF, Kluwe L, Friedrich RE et al (2010) Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions. J Med Genet 47:623-630